Abstract:Rational: Patients with hepatocellular carcinoma (HCC) have a poor prognosis mostly due to intrahepatic as well as distal metastasis. Vasodilator-stimulated phosphoprotein (VASP), a regulator of actin cytoskeleton and cell migration, is overexpressed in HCC and correlated with its malignant features and poor prognosis. Very little is known about its function in HCC. Methods: qRT-PCR, Western blot and IHC were used to detect the VASP expression in tissues and cells. Transwell and wound healing assays were used to measure the migration and invasion of HCC cells. Immunoblotting and immunofluorescence were used for detection of epithelial-to-mesenchymal transition (EMT) progression in HCC cells. A lung metastasis mouse model was used to evaluate metastasis of HCC in vivo. The putative targets of miR-204 were disclosed by public databases and a dual-luciferase reporter assay. IP was used to show the interaction between VASP and CRKL. ChIP was used to analyze the binding of HIF-1α to VASP promoter region. Results: Our data involving both gain- and loss-of-function studies revealed that VASP activated AKT and ERK signaling and promoted HCC migration and invasion in vitro and in vivo by altering the EMT phenotype and expression of MMPs. We investigated the positive correlation between VASP and an adapter protein, CRKL. VASP dynamically co-localized at the SH3N domain of CRKL and mediated its function. Mechanistically, VASP overexpression at the transcriptional level was mediated by HIF-1α through direct binding to two hypoxia response elements (HRE) in the VASP promoter region. Furthermore, we identified hypoxia-induced down-regulation of miR-204, which functioned as the regulator of VASP overexpression at the post-transcriptional level. Also, hypoxia-activated p-Smad3 dependent TGF-β signaling indirectly promoted VASP expression. Conclusion: A variety of hypoxia-induced molecular mechanisms contributed to the upregulation of VASP at transcriptional and post-transcriptional levels. These mechanisms involved CRKL, HIF-1α, miR-204, and TGF-β activating the AKT and ERK signaling to promote EMT and expression of MMPs. Taken together, our results defined VASP as an oncogene of HCC pathogenesis and metastasis with the potential to serve as a prognostic biomarker.

Transcription Factor Sp1 is Essential for Expression of VEGF in Human Hepatocellular Carcinoma Cells

Research Progress on Relationship Between Transcription Factor Sp1 and Tumor

Correlation of transcription factor Sp1 expression with clinical and pathological characteristics and prognosis of hepatocellular carcinoma

Constitutive Sp1 Activity is Essential for Differential Constitutive Expression of Vascular Endothelial Growth Factor in Human Pancreatic Adenocarcinoma.

The Effection of HGF/cMet Pathway on the Expression of VEGF in MHCC97H

Altered Expression of Transcription Factor Sp1 Critically Impacts the Angiogenic Phenotype of Human Gastric Cancer

Effect of Interferon αon the Expression and Activity of Transcription Factor Sp 1 in Hepatocarcinoma Cells

SP1 is required for basal activation and chromatin accessibility of CD151 promoter in liver cancer cells.

HIF-1α Promotes the Metastasis of Esophageal Squamous Cell Carcinoma by Targeting SP1

Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism

SP1 plays a pivotal role for basal activity of TIGAR promoter in liver cancer cell lines

Transcription Factor Specifidty Protein 1: a New Biomarker for Pancreatic Cancer Therapy

Sp1-regulated Transcription of RasGRP1 Promotes Hepatocellular Carcinoma (HCC) Proliferation

Upregulation of Heat Shock Factor 1 Transcription Activity is Associated with Hepatocellular Carcinoma Progression.

[Expression of Transcription Factor Sp1 in Human Gastric Cancer Tissue and Its Correlation with Prognosis].

Sp1‐mediated ectopic expression of T‐cell lymphoma invasion and metastasis 2 in hepatocellular carcinoma

Expression of Transcription Factor Sp1 in Human Pancreatic Ductal Carcinoma and Its Relationship with Prognosis

Hypoxia-induced Up-Regulation of VASP Promotes Invasiveness and Metastasis of Hepatocellular Carcinoma.

Identification of Sp1 As A Transcription Activator to Regulate Fibroblast Growth Factor 21 Gene Expression

Role of Thrombospondin-1 and Vascular Endothelial Growth Factor in Neovascularization of Hepatocellular Carcinoma

Transcriptional Activation of TMSG-1 by Complex of KLF6 and Sp1